Viriom’s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials
Viriom Inc., dedicated to advancing a pipeline of highly effective and broadly affordable treatments targeting infectious and malignant diseases globally, announces the successful completion and positive results of Phase I…